One particular obstacle in vaccine improvement is economic: Lots of the diseases most demanding a vaccine, which includes HIV, malaria and tuberculosis, exist principally in lousy countries. Pharmaceutical corporations and biotechnology companies have small incentive to acquire vaccines for these ailments simply because there is minimal profits pos